Tredje AP fonden Has $26.07 Million Stake in Veeva Systems Inc. $VEEV

Tredje AP fonden grew its holdings in Veeva Systems Inc. (NYSE:VEEV) by 11.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 90,516 shares of the technology company’s stock after acquiring an additional 8,970 shares during the quarter. Tredje AP fonden’s holdings in Veeva Systems were worth $26,067,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of VEEV. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Veeva Systems by 394.9% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 3,222 shares of the technology company’s stock worth $755,000 after acquiring an additional 2,571 shares in the last quarter. Amalgamated Bank increased its holdings in shares of Veeva Systems by 5.0% in the first quarter. Amalgamated Bank now owns 10,949 shares of the technology company’s stock worth $2,536,000 after acquiring an additional 520 shares in the last quarter. Mather Group LLC. increased its holdings in shares of Veeva Systems by 144.3% in the first quarter. Mather Group LLC. now owns 259 shares of the technology company’s stock worth $60,000 after acquiring an additional 153 shares in the last quarter. Private Trust Co. NA increased its holdings in shares of Veeva Systems by 35.0% in the first quarter. Private Trust Co. NA now owns 247 shares of the technology company’s stock worth $57,000 after acquiring an additional 64 shares in the last quarter. Finally, First Horizon Advisors Inc. increased its holdings in shares of Veeva Systems by 27.4% in the first quarter. First Horizon Advisors Inc. now owns 526 shares of the technology company’s stock worth $122,000 after acquiring an additional 113 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.

Insider Activity at Veeva Systems

In related news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the completion of the transaction, the insider directly owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Jonathan Faddis sold 14,595 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the transaction, the senior vice president directly owned 8,588 shares of the company’s stock, valued at $2,576,400. This trade represents a 62.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 24,665 shares of company stock valued at $7,438,000. Insiders own 10.30% of the company’s stock.

Veeva Systems Stock Performance

NYSE:VEEV opened at $291.20 on Friday. The company has a market cap of $47.73 billion, a PE ratio of 59.80, a PEG ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a 52-week low of $201.54 and a 52-week high of $310.50. The stock has a 50-day simple moving average of $285.22 and a 200 day simple moving average of $272.54.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The company had revenue of $789.08 million for the quarter, compared to analyst estimates of $768.49 million. During the same period last year, the company posted $1.62 earnings per share. The business’s revenue for the quarter was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, research analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on VEEV. Needham & Company LLC restated a “buy” rating and issued a $355.00 price target on shares of Veeva Systems in a report on Friday, October 17th. Citigroup increased their price target on Veeva Systems from $329.00 to $349.00 and gave the stock a “buy” rating in a report on Thursday, August 28th. Evercore ISI increased their price objective on Veeva Systems from $285.00 to $295.00 and gave the stock an “in-line” rating in a report on Thursday, August 28th. TD Cowen upgraded Veeva Systems from a “hold” rating to a “buy” rating and increased their price objective for the stock from $297.00 to $380.00 in a report on Tuesday, October 7th. Finally, Truist Financial increased their price objective on Veeva Systems from $268.00 to $275.00 and gave the stock a “hold” rating in a report on Thursday, August 28th. Seventeen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $307.58.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.